STOCK TITAN

Titan Medical Inc - TMDIF STOCK NEWS

Welcome to our dedicated news page for Titan Medical (Ticker: TMDIF), a resource for investors and traders seeking the latest updates and insights on Titan Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Titan Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Titan Medical's position in the market.

Rhea-AI Summary
Titan Medical Inc. settles dispute with a contract manufacturer by agreeing to pay US$2 million by June 24, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Titan Medical Inc. reported financial results for 2023, highlighting key activities such as new board appointments, licensing agreements, and a definitive amalgamation agreement with Conavi Medical Inc. The company improved its financial position with increased cash, working capital, and reduced financial obligations. Revenue significantly increased to $17.6 million, with a notable decrease in R&D and G&A expenses. Titan is focused on finalizing the amalgamation agreement with Conavi, subject to various approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
-
Rhea-AI Summary
Titan Medical Inc. announces a webcast Q&A session regarding its merger agreement with Conavi Medical Inc. Management will provide prepared remarks followed by a Q&A session on March 27, 2024. Shareholders can submit questions in advance until March 25, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
none
Rhea-AI Summary
Titan Medical Inc. announces a merger with Conavi Medical Inc. to create a leader in hybrid intravascular imaging. The combined company will focus on commercializing Conavi's Novasight Hybrid™ System. The transaction involves a reverse takeover of Titan, delisting from TSX, and listing on TSXV. Conavi's technology has regulatory approvals and is set to enhance patient care globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
-
Rhea-AI Summary
Titan Medical Inc. plans to release its year-end 2023 financial results on March 29, 2024, providing investors with crucial insights into the company's performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.12%
Tags
conferences earnings
-
Rhea-AI Summary
Titan Medical Inc. (TSX: TMD; OTC: TMDIF) faces manufacturing and supply agreement termination with Benchmark Electronics, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Titan Medical Inc. announces financial results for Q3 2023, with cash of $8.9 million and improved working capital of $7.6 million. Revenue was $0.5 million for Q3 2023, compared to $nil for Q3 2022. R&D expenses decreased significantly due to cost-cutting measures. G&A expenses also decreased in the current period. Full financial statements and analysis available at www.sedarplus.ca.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Titan Medical Inc. announces change of auditor
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Titan Medical Inc. enters licensing agreement with Auris Health, granting a non-exclusive license to a portion of Titan's IP.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
management
Titan Medical Inc

OTC:TMDIF

TMDIF Rankings

TMDIF Stock Data

5.70M
113.51M
0.42%
0.37%
1.33%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Canada
Toronto

About TMDIF

titan medical inc. is a canadian public company (tsx venture:tmd)(otcqx:titxf) focused on the design, development and commercialization of new robotic surgical technologies. for more information on titan medical inc. please visit www.titanmedicalinc.com.